|
Сообщение от Olga&M
Я как вспомню, как мучалась моя дочка в 2,5 года с ветрянкой.....лучше бы у нас прививки делали.
|
|
Сообщение от Olga&M
Я не врач, и о пользе или вреде прививок не знаю, но своей дочке все прививки делаю.
|
|
Сообщение от Poohlik
А если я сама всеми этими детскими болела (кроме краснухи) через молоко хоть что-то передасться?
|
|
Сообщение от Poohlik
А еще дошла информация, что в качестве консерванта используют соли ртути, которые могут вызвать аутизм (это наверное тяжелое последствие прививки) или это все неправда?
|
|
Сообщение от Poohlik
что тогда делают таким деткам? Не ставят вообще прививку?В таком случае можно вообще ее не ставить. Получается так.
|
|
Сообщение от Poohlik
... у нас есть 3 вакцины АКДС, 3 ИПВ и 2 от гепатита В. Остальные детские болезни меня не пугают своими последствиями, кроме кори, там что-то даже и слепота в тяжелых случаях.
Я в общем-то не против прививок, но что-то много их делают в годик то... |
| А еще дошла информация, что в качестве консерванта используют соли ртути, которые могут вызвать аутизм (это наверное тяжелое последствие прививки) или это все неправда? |
| По поводу Манту: Ведь есть еще способ ПЦР. Он намного точнее. Пусть и стоит дорого, но я бы раз в год лучше это делала Сашке, чем колоть ее всякой бякой. Или я опять ошибаюсь? |
|
Сообщение от Fantasia
в прошлом году мне делали пробу на иммунитет к краснухе и обнаружили антитела... как такое может быть, не понимаю -- ни я, ни моя мама не болели ею...
|
|
Сообщение от Poohlik
...предыдущие прививки мы делали исключительно из-за своей темноты. в общем отказываюсь и все.
|
|
Сообщение от Poohlik
Лен! В общем то я прививки не считаю абсолютным злом, но если бы ты видела как моя Сашенька синеет от плача, когда ей колют в попку, то я представляю, что будет, если будут колоть в ручку
|

|
Сообщение от Timka
Если ребенок вырывается, правильно поставить внутрикожнуюпробу почти невозможно. Так что, если надумаешь сделать эту пробу, распроси доктора, как это будет происходить у вас. Обычно, дети даже испугаться не успевают, как проба поставлена, когда используют безыгольный инъектор. |
|
Сообщение от Elena Hearst
Девочки,у кого дочки уже 10-15 летние,что вы слышали о прививке HPV-human papilloma virus? Ставили ли вы её,так ли "страшен чёрт,как говорят о нём"? Сегодня врач предложил сделать эту прививку,вот и думаю над этим...
![]() |
|
A researcher who worked on a vaccine for the human papillomavirus is warning that it hasn't been tested on young girls, is "silly" for states to mandate the vaccination, and in a worst-case scenario could even increase cervical cancer rates. In a report published by the Indiana-based Daily News, researcher Diane M. Harper said giving such a vaccine to 11-year-olds "is a great big public health experiment." Further, she said, requiring vaccinations now "is simply to Merck's benefit |
| And she warned more than 40 cases of Guillian-Barre syndrome – an immune disorder that results in tingling, numbness and even paralysis of the muscles – have been reported in girls who got the HPV vaccine in combination with a meningitis vaccine. |
|
Family claims cervical-cancer vaccine caused paralysis Health Department disputes that determination by Jo Rafferty Nevada Appeal News Service May 17, 2007 Fourteen-year-old Jessica Vega went into the emergency room at Renown Regional Medical Center in Reno on Thursday night when she couldn't move her legs and her arms felt weak. "Her legs are paralyzed, her arms are affected. She is very weak in her arms," said Tondra Vees a family friend. "She has to use a walker. Even with that, she can't get to the bathroom. She can't stand up at all." Vees said the girl has been determined by her doctor to have Guillain-Barre syndrome, an acute, autoimmune condition that can lead to paralysis. The girl, whose mother Rhonda Vega is a full-time teacher's aide at Carson Valley Middle School, received her first booster shot of the cervical cancer prevention vaccine Gardasil on May 2. "According to her neurologist, that's what caused this," said Vees, Nevada State Health Officer Dr. Bradford Lee said the Web sites the Nevada State Health Department checks don't list the girl's symptoms as a side-effect. "We are aware of a report of an alleged side-effect," said Lee. "Based on the CDC's site and the manufacturer's site, this is not a side-effect of the vaccine." Vees said the girl has been determined by her doctor to have Guillain-Barre syndrome, an acute, autoimmune condition that can lead to paralysis. Vees said the girl was being moved to a rehabilitation center on Tuesday. "Thankfully, since Thursday, it doesn't appear to be ending up in her respiratory system, although she's getting weaker," Vees said. "They were going to let her go home, but now she's not. I think they expect her to be in (rehabilitation) for a month or so." Vees cites a Feb. 21 report on the National Vaccine Information Center Web site, nvic.org, in which NVIC president Barbara Loe Fisher states, "There are twice as many children collapsing and four times as many children experiencing tingling, numbness and loss of sensation after getting a Gardasil vaccination compared to those getting a TDAP (tetanus-diphtheria-acellular pertussis) vaccination. There have been reports of facial paralysis and Guillain-Barre syndrome." Vees cites that according to nvic.org, the vaccine's manufacturer, Merck & Co., studied Gardasil in fewer than 1,200 girls younger than age 16 in "pre-licensure trials." According to Vees, the girl had not received any other vaccines at the same time, and prior to Thursday was "healthy as a horse." Public information officer Martha Framsted and Lee, both of the Nevada State Health Department, said Monday they check for vaccine information only from government-approved Web sites. "We always try to go to the Web sites that have been scientifically proven," said Framsted. "I don't believe (the National Vaccine Information Center) is one of our federal partners." The agencies the health department does check with before approving a vaccine are the Center for Disease Control and Prevention (www.cdc.gov), the manufacturer's Web site (in this case gardasil.com and merckvaccines.com) and with the Advisory Committee on Immunization Practices, the only entity in the federal government which can make recommendations regarding routine administration of vaccines, according to the CDC. The Web site gardasil.com states that the only side effects are "pain, swelling, itching and redness at the injection site, fever, nausea and dizziness." Neither Lee nor Framsted wanted to speculate on why the doctor would say the girl's paralysis was a side-effect of the vaccine. According to Bonnie Dellner, the chief school nurse for the Douglas County School District, the normal cost for the three vaccinations of Gardasil is $500. The school district offers these vaccines at $15 each. Dellner said the school had received no complaints after an April 29 immunization clinic at Douglas High School. The U.S. Food and Drug Administration approved Gardasil on June 8. Gardasil is for girls and women ages 9 to 26. Gardasil is the only vaccine that may help guard against diseases caused by HPV, which may cause cervical cancer. |
|
Judicial Watch Uncovers Three Deaths Relating to HPV Vaccine For Immediate Release May 23, 2007 Contact: Press Office 202-646-5188 Judicial Watch Uncovers Three Deaths Relating to HPV Vaccine Event Reports Obtained from FDA Detail 1,637 Adverse Reactions to Gardasil Read this on Judicial Watch's Web Site: http://judicialwatch.... (Washington, DC) -- Judicial Watch, the public interest group that investigates and prosecutes government corruption, today released documents obtained from the U.S. Food and Drug Administration (FDA) under the provisions of the Freedom of Information Act, detailing 1,637 reports of adverse reactions to the vaccination for human papillomavirus (HPV), Gardasil. Three deaths were related to the vaccine. One physician’s assistant reported that a female patient “died of a blood clot three hours after getting the Gardasil vaccine.” Two other reports, on girls 12 and 19, reported deaths relating to heart problems and/or blood clotting. |
|
Analysis Shows Greater Risk of GBS Reports When HPV Vaccine Is Given with Meningococcal and Other Vaccines Washington, August 15, 2007 The National Vaccine Information Center (NVIC) today issued a new report on HPV vaccine (Gardasil®) safety analyzing adverse event reports to the federal Vaccine Adverse Event Reporting System (VAERS). The analysis gives evidence for a reported association in VAERS between Gardasil and Guillain-Barre Syndrome (GBS), with a statistically significant increased risk of GBS and other serious adverse event reports when Gardasil is co-administered with other vaccines, especially meningococcal vaccine (Menactra®). NVIC is calling on the Centers for Disease Control (CDC) to issue an Advisory and amend its March 12 policy by alerting the public that Gardasil has been associated with 15 cases of GBS and an increased risk of GBS and other serious adverse event reports made to VAERS when the vaccine is administered simultaneously with Menactra and other vaccines. “The precautionary principle dictates that good science should precede CDC vaccine policy recommendations,” said Barbara Loe Fisher, NVIC co-founder and president. “Parents have a right to expect proof of safety and not assumption of safety before new vaccines, like Gardasil, are given simultaneously with other vaccines to their children. GBS is a disorder in which the body’s immune system attacks part of the peripheral nervous system, and can cause total paralysis. “Our analysis of Gardasil reports to VAERS indicates there was a two to 12 times greater likelihood that serious adverse events, such as GBS, were reported when Gardasil was given in combination with Menactra rather than given alone,” said Vicky Debold, PhD, RN, NVIC director of patient safety. “Accepted scientific standards indicate that these findings are statistically significant and cannot be dismissed as coincidence. In particular, the available VAERS data show there was a more than 1,000 percent increased risk of GBS reports following Gardasil administration when Menactra was given at the same time.” Reported GBS and Other Serious Adverse Events NVIC found that, as of May 31, there have been 2,227 Gardasil adverse events filed with VAERS, including 13 suspected or confirmed cases of GBS (two more GBS reports were made in June for a total of 15) and 239 cases of syncope (fainting with temporary loss of consciousness), many of which resulted in head injuries and fractures. Seven deaths have been reported after receipt of Gardasil. Nearly 10 percent of all Gardasil adverse event reports to VAERS involved avoidable medical errors. A total of 1,930 reported Gardasil adverse events involved administration of Gardasil alone, and 135 adverse events involved co-administration of Gardasil with Menactra. NVIC’s comparative analysis of those two categories of VAERS reports indicates that when Gardasil was given simultaneously with Menactra rather than alone, there was a statistically significant increased risk of reported adverse events: respiratory problem reports increased by 114 percent; cardiac problems reports increased by 118 percent; neuromuscular and coordination problem reports increased by 234 percent; convulsions and central nervous system problem reports increased by 301 percent; reports of injuries from falls after unconsciousness increased by 674 percent; and GBS reports increased by 1,130 percent. On February 21, NVIC expressed concern about the safety of administering Gardasil simultaneously with other vaccines because the manufacturer (Merck), the FDA and the CDC had not provided evidence to the public that co-administration was safe. (1) On March 12, the CDC published recommendations for Gardasil use in MMWR that acknowledged there is a lack of evidence that Gardasil can be safely administered with other vaccines, while encouraging physicians to co-administer Menactra and other vaccines with Gardasil based on assumption of safety. (2) Adverse Event Reports to NVIC: Shannon Nelson Nineteen Gardasil adverse event reports from 12 states have been made to NVIC’s Vaccine Reaction Registry involving unconsciousness and injury, convulsions, numbness, weakness and other neuromuscular and coordination problems and GBS. Shannon Nelson, 18, a Chicago area athlete, musician and artist entering college reported to NVIC that she received HPV vaccine (Gardasil), meningococcal vaccine (Menactra) and chicken pox vaccine (Varivax ®) simultaneously on June 21. Symptoms of tingling, numbness and muscle weakness began within a week and progressively got worse. By July 3 she could barely walk or raise her arms. She was hospitalized, paralyzed with GBS on July 5, and spent 22 days in the hospital. “Before the shots, I ran six miles a day,” said Nelson. “The doctors told me that I might have been put on a respirator if I hadn’t been in such good shape,” she said. “I am out of the hospital now and getting a lot of physical therapy. I just want to go to college and do the things I did before, like play the guitar and draw or even just be able to smile. My Mom and I wish we had known about HPV vaccine risks, especially what could happen if I got other vaccines at the same time.” To view a copy of NVIC’s report on HPV vaccine (Gardasil) safety, go to http://www.nvic.org/Diseases/HPV/HPVHOME.htm. To report a vaccine reaction, go to https://www.nvic.org/report/reaction.htm ****** Founded in 1982, the National Vaccine Information Center (NVIC) is a non-profit 501(C)3 organization working for child health, public education and consumer empowerment. NVIC is dedicated to preventing vaccine injuries and deaths through public education and defending the right to informed consent to vaccination. NVIC has operated a private Vaccine Reaction Registry for 25 years. References: 1) Vaccine Safety Group Releases Gardasil Report: Calls on FDA and CDC to Warn Doctors and Parents to Report to VAERS, February 21, 2007 http://www.nvic.org/Diseases/HPV/pr022107HPV.htm. 2) Centers for Disease Control and Prevention. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR) Early Release 2007; 56 March 12, 2007:1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr56e312a1.htm |
vBulletin Copyright ©2000 - 2008,
.
Copyright Russian Meeting Place